Some of the content on this website requires JavaScript to be enabled in your web browser to function as intended. While the website is still usable without JavaScript, it should be enabled to enjoy the full interactive experience.

Skip to Main Navigation. Each navigation link will open a list of sub navigation links.

Skip to Main Content

Department of Molecular Biology|College of Agriculture and Natural Resources

Contact Don Jarvis

Department of Molecular Biology
University of Wyoming
1000 E. University Ave.
Laramie, WY 82071

Email: DLJarvis@uwyo.edu

Phone: (307) 766-4282

Jarvis Lab: Current Research Support

Current research support:

  1. NIH (U54 AI065357; collaboration with Ken Olson, CSU and Ann Powers, CDC):
    “Development of a novel antiviral therapy targeting multiple alphaviruses”.
    05/01/09 to 04/30/14.
  2. NIH (P41 GM103390-23S; collaboration with Kelley Moremen, Univ. of Georgia):
    “Repository of Glycan-related Enzymes and Expression Constructs”.
    08/01/11 to 07/31/14.
  3. NIH (R44 GM09311; collaboration with Paratechs Corp):
    “Enhancing mammalian glycoprotein production in the baculovirus expression vector system”
    12/01/12 to 11/30/14.
  4. NIH (R43 GM102982, collaboration with Christoph Geisler, GlycoBac, LLC):
    "Glycoengineering insect cells for commercial recombinant glycoprotein production.".
    7-1-13 to 6-30-15.

Pending research support:

  1. NIH (R43 GM109504, collaboration with Christoph Geisler, GlycoBac, LLC):
    "Engineering cells for concurrent protein drug biosynthesis and polysialylation".
    11-1-13 to 4-30-14.
  2. NIH (CTER U19; collaboration with Ken Olson, Colorado State University):
    "Integrated arboviral disease control through novel broad-spectrum countermeasures”.
    4-1-14 to 3-28-19.
  3. NIH (IMVZ U19; collaboration with Tony Schountz, Colorado State University):
    "Immune mechanisms of zoonotic viruses".
    4-1-14 to 3-28-19.
  4. NIH (RO1 GM110653):
    "Glycoprotein processing in the baculovirus-insect cell system".
    4-1-14 to 3-30-18.
  5. NIH RO1 (collaboration with Tony Shountz, Colorado State University):
    "Factors governing immunopathology, persistence or clearance of New World Hantaviruses".
    4-1-14 to 3-30-19.
  6. NIH R01 (collaboration with Ken Olson, Colorado State University):
    "Development of a novel vaccination strategy targeting multiple alphaviruses”.
    5-1-14 to 4-30-19.

(Last update 08/27/13)

Share This Page:

Footer Navigation

University of Wyoming Medallion
 
1000 E. University Ave. Laramie, WY 82071 // UW Operators (307) 766-1121 // Contact Us // Download Adobe Reader